Related Experiment Videos
Depressive symptom trajectories during and after adjuvant treatment for breast cancer
Kristine A Donovan1, Brian D Gonzalez, Brent J Small
1Health Outcomes and Behavior Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, MRC-PSY, Tampa, FL, 33612, USA, kristine.donovan@moffitt.org.
Background:
The course of depressive symptoms during and after breast cancer treatment is not well understood.
Purpose:
We identified patient subgroups based on distinct trajectories of depressive symptoms and determined whether subgroups could be distinguished by personal characteristics and coping strategies.
Methods:
Breast cancer patients completed the Center for Epidemiologic Studies-Depression Scale on clinically meaningful occasions and during the posttreatment period. The Illness Management Questionnaire was completed prior to treatment.
Results:
A three-class mixture model provided the best fit to the data. Subgroup membership was significantly (p < .05) associated with marital status, history of depression, and focusing on symptoms. In multivariate analysis, marital status and focusing on symptoms remained significant (p < .05) predictors of subgroup membership.
Conclusions:
Distinct trajectories can be identified during and after adjuvant breast cancer therapy. Predictors of these trajectories have implications for addressing depressive symptoms in this clinical population and for future research.
Related Concept Videos
Treatment Resistant Cancers
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Cancer Survival Analysis